Clinical research

Two-year clinical outcomes of paclitaxel-eluting stents for in-stent restenosis in patients from the ARRIVE programme

EuroIntervention 2011;7:314-322. DOI: 10.4244/EIJV7I3A55

Michael S. Lee
Michael S. Lee1*, MD; Tae Yang1, MD; John M. Lasala2, MD, PhD; David A. Cox3, MD; Thomas S. Bowman4, MD, MPH; Ruth M. Starzyk4, PhD; Keith D. Dawkins4, MD
1. UCLA Medical Center, Los Angeles, CA, USA; 2. Washington University School of Medicine, St. Louis, MO, USA; 3. Lehigh Valley Hospital, Allentown, PA, USA; 4. Boston Scientific Corporation, Natick, MA, USA

Aims: To examine the incidence of clinical events after implantation of the TAXUS Express paclitaxel-eluting stent (PE

No account yet?
Sign up for free!

Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from

coronary diseasein-stent restenosispercutaneous coronary interventionpaclitaxel-eluting stentregistries
Read next article
Late lumen loss and intima hyperplasia after sirolimus-eluting and zotarolimus-eluting stent implantation in diabetic patients: the diabetes and drug-eluting stent (DiabeDES III) angiography and intravascular ultrasound trial

Latest news